375 related articles for article (PubMed ID: 26728869)
1. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
2. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.
Shen W; Paxton CN; Szankasi P; Longhurst M; Schumacher JA; Frizzell KA; Sorrells SM; Clayton AL; Jattani RP; Patel JL; Toydemir R; Kelley TW; Xu X
J Clin Pathol; 2018 Apr; 71(4):372-378. PubMed ID: 29197855
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
[TBL] [Abstract][Full Text] [Related]
4. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
6. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
Shen W; Szankasi P; Durtschi J; Kelley TW; Xu X
Methods Mol Biol; 2019; 1908():113-124. PubMed ID: 30649724
[TBL] [Abstract][Full Text] [Related]
8. DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data.
Kang Y; Nam SH; Park KS; Kim Y; Kim JW; Lee E; Ko JM; Lee KA; Park I
BMC Bioinformatics; 2018 Oct; 19(1):381. PubMed ID: 30326846
[TBL] [Abstract][Full Text] [Related]
9. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
[TBL] [Abstract][Full Text] [Related]
10. Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.
Overwater E; Marsili L; Baars MJH; Baas AF; van de Beek I; Dulfer E; van Hagen JM; Hilhorst-Hofstee Y; Kempers M; Krapels IP; Menke LA; Verhagen JMA; Yeung KK; Zwijnenburg PJG; Groenink M; van Rijn P; Weiss MM; Voorhoeve E; van Tintelen JP; Houweling AC; Maugeri A
Hum Mutat; 2018 Sep; 39(9):1173-1192. PubMed ID: 29907982
[TBL] [Abstract][Full Text] [Related]
11. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of copy number alteration detection using panel-based next-generation sequencing data in myelodysplastic syndrome.
Kim YJ; Jung SH; Hur EH; Choi EJ; Lee KH; Park HC; Kim HJ; Kwon YR; Park S; Lee SH; Chung YJ; Lee JH
Leuk Res; 2021 Apr; 103():106540. PubMed ID: 33667811
[TBL] [Abstract][Full Text] [Related]
13. Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours.
Bartlett J; Amemiya Y; Arts H; Bayani J; Eng B; Grafodatskaya D; Kamel Reid S; Lariviere M; Lo B; McClure R; Mittal V; Sadikovic B; Sadis S; Seth A; Smith J; Zhang X; Feilotter H
PLoS One; 2021; 16(10):e0258188. PubMed ID: 34597339
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.
Cao Y; Jin Y; Yu J; Wang J; Qiu Y; Duan X; Ye Y; Cheng Y; Dong L; Feng X; Wang D; Li Z; Tian X; Wang H; Yan J; Zhao Q
Oncotarget; 2017 Jul; 8(30):49689-49701. PubMed ID: 28591696
[TBL] [Abstract][Full Text] [Related]
15. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
16. CoNVaDING: Single Exon Variation Detection in Targeted NGS Data.
Johansson LF; van Dijk F; de Boer EN; van Dijk-Bos KK; Jongbloed JD; van der Hout AH; Westers H; Sinke RJ; Swertz MA; Sijmons RH; Sikkema-Raddatz B
Hum Mutat; 2016 May; 37(5):457-64. PubMed ID: 26864275
[TBL] [Abstract][Full Text] [Related]
17. Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations.
Sarhadi VK; Lahti L; Scheinin I; Tyybäkinoja A; Savola S; Usvasalo A; Räty R; Elonen E; Ellonen P; Saarinen-Pihkala UM; Knuutila S
Genomics; 2013 Sep; 102(3):182-8. PubMed ID: 23333812
[TBL] [Abstract][Full Text] [Related]
18. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
[TBL] [Abstract][Full Text] [Related]
19. Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.
Lopes LR; Murphy C; Syrris P; Dalageorgou C; McKenna WJ; Elliott PM; Plagnol V
Eur J Med Genet; 2015 Nov; 58(11):611-6. PubMed ID: 26455666
[TBL] [Abstract][Full Text] [Related]
20. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
